FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017020170> ?p ?o ?g. }

• W2017020170 endingPage "59" @default.
• W2017020170 startingPage "55" @default.
• W2017020170 abstract "Here we demonstrate 2 patients who showed marked hyperglycemia after androgen-deprivation therapy for prostate cancer and the efficacy of the thiazolidinedione pioglitazone on their glycemic control. Case 1 was a 61-year-old man diagnosed with prostate cancer who had type 2 diabetes mellitus for 7 years. His glycemic control had been good for the previous 5 years because of diet therapy and acarbose administration. He was given the gonadotropin-releasing hormone agonist leuprolide acetate and the androgen receptor antagonist flutamide for the treatment of prostate cancer. After the second injection of leuprolide acetate, fasting glucose and hemoglobin A1c (HbA1c) levels were found to be markedly elevated (22.8 mmol/L and 10.5%, respectively). Case 2 was an 81-year-old man whose fasting glucose and HbA1c had been normal 10 months ago. He was injected with leuprolide acetate for the treatment of prostate cancer. Six months after starting the leuprolide treatment, the patient complained of thirst and weight loss and was diagnosed with diabetes mellitus with a fasting glucose of 19.4 mmol/L and HbA1c of 9.9%. The correct homeostasis model assessment evaluation indexes for pancreatic beta-cell function (HOMA-%beta )A and for insulin sensitivity (HOMA-%S) were reduced in these 2 patients compared with control men. Their serum testosterone and 17beta -estradiol concentrations were depressed. After improvement of hyperglycemia by insulin treatment, their glycemic control remained good after treatment with pioglitazone without use of insulin. The values of HOMA-%beta and HOMA-%S increased to control ranges. Insulin resistance after the androgen-deprivation therapy might lead to marked hyperglycemia in these patients." @default.
• W2017020170 created "2016-06-24" @default.
• W2017020170 creator A5000956521 @default.
• W2017020170 creator A5013604895 @default.
• W2017020170 creator A5029185764 @default.
• W2017020170 creator A5034053698 @default.
• W2017020170 creator A5067648433 @default.
• W2017020170 creator A5077224975 @default.
• W2017020170 creator A5082581543 @default.
• W2017020170 creator A5084231732 @default.
• W2017020170 creator A5090675780 @default.
• W2017020170 date "2005-01-01" @default.
• W2017020170 modified "2023-09-28" @default.
• W2017020170 title "Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment" @default.
• W2017020170 cites W1993669370 @default.
• W2017020170 cites W2002676453 @default.
• W2017020170 cites W2005383842 @default.
• W2017020170 cites W2005671531 @default.
• W2017020170 cites W2016392921 @default.
• W2017020170 cites W2037112420 @default.
• W2017020170 cites W2053764212 @default.
• W2017020170 cites W2066898102 @default.
• W2017020170 cites W2075327866 @default.
• W2017020170 cites W2079076810 @default.
• W2017020170 cites W2085260284 @default.
• W2017020170 cites W2132837172 @default.
• W2017020170 cites W2141759136 @default.
• W2017020170 cites W2160234571 @default.
• W2017020170 cites W4229483718 @default.
• W2017020170 cites W4246753467 @default.
• W2017020170 cites W4250655755 @default.
• W2017020170 doi "https://doi.org/10.1016/j.metabol.2004.07.010" @default.
• W2017020170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15562380" @default.
• W2017020170 hasPublicationYear "2005" @default.
• W2017020170 type Work @default.
• W2017020170 sameAs 2017020170 @default.
• W2017020170 citedByCount "46" @default.
• W2017020170 countsByYear W20170201702014 @default.
• W2017020170 countsByYear W20170201702015 @default.
• W2017020170 countsByYear W20170201702016 @default.
• W2017020170 countsByYear W20170201702017 @default.
• W2017020170 countsByYear W20170201702018 @default.
• W2017020170 countsByYear W20170201702019 @default.
• W2017020170 countsByYear W20170201702020 @default.
• W2017020170 countsByYear W20170201702021 @default.
• W2017020170 countsByYear W20170201702023 @default.
• W2017020170 crossrefType "journal-article" @default.
• W2017020170 hasAuthorship W2017020170A5000956521 @default.
• W2017020170 hasAuthorship W2017020170A5013604895 @default.
• W2017020170 hasAuthorship W2017020170A5029185764 @default.
• W2017020170 hasAuthorship W2017020170A5034053698 @default.
• W2017020170 hasAuthorship W2017020170A5067648433 @default.
• W2017020170 hasAuthorship W2017020170A5077224975 @default.
• W2017020170 hasAuthorship W2017020170A5082581543 @default.
• W2017020170 hasAuthorship W2017020170A5084231732 @default.
• W2017020170 hasAuthorship W2017020170A5090675780 @default.
• W2017020170 hasConcept C121608353 @default.
• W2017020170 hasConcept C126322002 @default.
• W2017020170 hasConcept C134018914 @default.
• W2017020170 hasConcept C2776923340 @default.
• W2017020170 hasConcept C2777180221 @default.
• W2017020170 hasConcept C2777391703 @default.
• W2017020170 hasConcept C2777899217 @default.
• W2017020170 hasConcept C2778313021 @default.
• W2017020170 hasConcept C2778384471 @default.
• W2017020170 hasConcept C2778535154 @default.
• W2017020170 hasConcept C2779279991 @default.
• W2017020170 hasConcept C2779306644 @default.
• W2017020170 hasConcept C2780192828 @default.
• W2017020170 hasConcept C2780473172 @default.
• W2017020170 hasConcept C555293320 @default.
• W2017020170 hasConcept C61367390 @default.
• W2017020170 hasConcept C71924100 @default.
• W2017020170 hasConceptScore W2017020170C121608353 @default.
• W2017020170 hasConceptScore W2017020170C126322002 @default.
• W2017020170 hasConceptScore W2017020170C134018914 @default.
• W2017020170 hasConceptScore W2017020170C2776923340 @default.
• W2017020170 hasConceptScore W2017020170C2777180221 @default.
• W2017020170 hasConceptScore W2017020170C2777391703 @default.
• W2017020170 hasConceptScore W2017020170C2777899217 @default.
• W2017020170 hasConceptScore W2017020170C2778313021 @default.
• W2017020170 hasConceptScore W2017020170C2778384471 @default.
• W2017020170 hasConceptScore W2017020170C2778535154 @default.
• W2017020170 hasConceptScore W2017020170C2779279991 @default.
• W2017020170 hasConceptScore W2017020170C2779306644 @default.
• W2017020170 hasConceptScore W2017020170C2780192828 @default.
• W2017020170 hasConceptScore W2017020170C2780473172 @default.
• W2017020170 hasConceptScore W2017020170C555293320 @default.
• W2017020170 hasConceptScore W2017020170C61367390 @default.
• W2017020170 hasConceptScore W2017020170C71924100 @default.
• W2017020170 hasIssue "1" @default.
• W2017020170 hasLocation W20170201701 @default.
• W2017020170 hasLocation W20170201702 @default.
• W2017020170 hasOpenAccess W2017020170 @default.
• W2017020170 hasPrimaryLocation W20170201701 @default.
• W2017020170 hasRelatedWork W138803513 @default.
• W2017020170 hasRelatedWork W1986132654 @default.
• W2017020170 hasRelatedWork W1994230976 @default.

• next